Federico Piacentini

3.6k total citations
115 papers, 1.9k citations indexed

About

Federico Piacentini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Federico Piacentini has authored 115 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 58 papers in Pulmonary and Respiratory Medicine and 51 papers in Cancer Research. Recurrent topics in Federico Piacentini's work include HER2/EGFR in Cancer Research (50 papers), Advanced Breast Cancer Therapies (44 papers) and Breast Cancer Treatment Studies (41 papers). Federico Piacentini is often cited by papers focused on HER2/EGFR in Cancer Research (50 papers), Advanced Breast Cancer Therapies (44 papers) and Breast Cancer Treatment Studies (41 papers). Federico Piacentini collaborates with scholars based in Italy, Spain and United States. Federico Piacentini's co-authors include Pierfranco Conté, Valentina Guarneri, Maria Vittoria Dieci, Guido Ficarra, Claudia Omarini, Elena Barbieri, Massimo Dominici, Stefania Bettelli, Antonino Maiorana and Antonio Frassoldati and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Federico Piacentini

103 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Piacentini Italy 23 1.3k 718 517 386 328 115 1.9k
Lorenzo Gianni Italy 21 1.2k 0.9× 600 0.8× 526 1.0× 405 1.0× 298 0.9× 91 2.0k
Zhimin Shao China 22 1.1k 0.9× 557 0.8× 557 1.1× 516 1.3× 290 0.9× 90 1.8k
Alessandro Marco Minisini Italy 24 1.1k 0.8× 589 0.8× 603 1.2× 425 1.1× 147 0.4× 76 1.9k
Ying Fan China 23 1.1k 0.8× 697 1.0× 513 1.0× 542 1.4× 194 0.6× 120 1.7k
Jennifer Eng‐Wong United States 20 1.5k 1.1× 647 0.9× 711 1.4× 245 0.6× 418 1.3× 59 2.0k
Lorenzo Gerratana Italy 26 1.4k 1.1× 1.0k 1.4× 855 1.7× 645 1.7× 141 0.4× 145 2.3k
Gabriella Mariani Italy 19 1.2k 0.9× 831 1.2× 308 0.6× 464 1.2× 373 1.1× 54 1.9k
Marta Gil-Martín Spain 20 1.2k 0.9× 322 0.4× 526 1.0× 629 1.6× 324 1.0× 108 2.0k
Mayu Yunokawa Japan 25 1.1k 0.8× 373 0.5× 482 0.9× 511 1.3× 312 1.0× 140 2.1k
Zhongsheng Tong China 20 1.2k 0.9× 372 0.5× 754 1.5× 324 0.8× 264 0.8× 105 1.7k

Countries citing papers authored by Federico Piacentini

Since Specialization
Citations

This map shows the geographic impact of Federico Piacentini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Piacentini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Piacentini more than expected).

Fields of papers citing papers by Federico Piacentini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Piacentini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Piacentini. The network helps show where Federico Piacentini may publish in the future.

Co-authorship network of co-authors of Federico Piacentini

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Piacentini. A scholar is included among the top collaborators of Federico Piacentini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Piacentini. Federico Piacentini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benatti, Stefania, et al.. (2025). Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows. Biomedicines. 13(2). 455–455. 3 indexed citations
2.
Farina, Alessandro, Federica Caggia, Monica Barbolini, et al.. (2025). Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. Breast Cancer Targets and Therapy. Volume 17. 53–66. 1 indexed citations
3.
4.
5.
Conté, Pierfranco, Maria Vittoria Dieci, Giancarlo Bisagni, et al.. (2024). A-BRAVE trial: A phase III randomized trial with avelumab in early triple-negative breast cancer with residual disease after neoadjuvant chemotherapy or at high risk after primary surgery and adjuvant chemotherapy.. Journal of Clinical Oncology. 42(17_suppl). LBA500–LBA500. 16 indexed citations
6.
Bettelli, Stefania, Monica Barbolini, Luca Moscetti, et al.. (2024). Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients. International Journal of Molecular Sciences. 25(5). 2490–2490. 1 indexed citations
7.
Omarini, Claudia, Angela Toss, Ilenia Mastrolia, et al.. (2024). 417P EV derived miR-21 as a promising biomarker for early diagnosis and tumor activity in discrete BC subtypes: The Exobreast project. Annals of Oncology. 35. S395–S395. 1 indexed citations
8.
Dieci, Maria Vittoria, Pierfranco Conté, Giancarlo Bisagni, et al.. (2023). Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer. JNCI Journal of the National Cancer Institute. 116(1). 69–80. 2 indexed citations
9.
Barbieri, Elena, Marta Venturelli, Federico Piacentini, et al.. (2023). Personalized Systemic Therapies in Hereditary Cancer Syndromes. Genes. 14(3). 684–684. 7 indexed citations
10.
Omarini, Claudia, Federico Piacentini, Isabella Sperduti, et al.. (2022). T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. BMC Cancer. 22(1). 623–623. 6 indexed citations
11.
Piacentini, Federico, Claudia Omarini, Angela Toss, et al.. (2022). Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. International Journal of Molecular Sciences. 23(13). 7079–7079. 9 indexed citations
12.
Benatti, Stefania, Gabriele Luppi, Ingrid Garajová, et al.. (2022). Carcinoid Crisis: A Misunderstood and Unrecognized Oncological Emergency. Cancers. 14(3). 662–662. 10 indexed citations
13.
Griguolo, Gaia, Maria Vittoria Dieci, Laia Paré, et al.. (2021). Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer. npj Breast Cancer. 7(1). 12–12. 15 indexed citations
14.
Piacentini, Federico, Ilenia Mastrolia, Valentina Masciale, et al.. (2021). Circulating and Intracellular miRNAs as Prognostic and Predictive Factors in HER2-Positive Early Breast Cancer Treated with Neoadjuvant Chemotherapy: A Review of the Literature. Cancers. 13(19). 4894–4894. 8 indexed citations
15.
Rimini, Margherita, Annarita Pecchi, Massimiliano Salati, et al.. (2021). The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center. Journal of Clinical Medicine. 10(8). 1705–1705. 7 indexed citations
16.
Garajová, Ingrid, Giulia Rovesti, Rita Balsano, et al.. (2021). The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review. Pharmaceuticals. 14(1). 43–43. 9 indexed citations
17.
Omarini, Claudia, Annarita Pecchi, Sara Balduzzi, et al.. (2019). <p>Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy</p>. Cancer Management and Research. Volume 11. 9563–9569. 20 indexed citations
18.
Omarini, Claudia, Giorgia Guaitoli, Stefania Pipitone, et al.. (2018). Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going. Cancer Management and Research. Volume 10. 91–103. 56 indexed citations
19.
Dieci, Maria Vittoria, Antonio Frassoldati, Daniele Generali, et al.. (2017). Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials. Breast Cancer Research and Treatment. 163(2). 295–302. 20 indexed citations
20.
Guarneri, Valentina, et al.. (2010). Achievements and unmet needs in the management of advanced ovarian cancer. Gynecologic Oncology. 117(2). 152–158. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lorenzo Gianni Breakdown of academic impact, for papers by Zhimin Shao Breakdown of academic impact, for papers by Alessandro Marco Minisini Breakdown of academic impact, for papers by Ying Fan Breakdown of academic impact, for papers by Jennifer Eng‐Wong Breakdown of academic impact, for papers by Lorenzo Gerratana Breakdown of academic impact, for papers by Gabriella Mariani Breakdown of academic impact, for papers by Marta Gil-Martín Breakdown of academic impact, for papers by Mayu Yunokawa Breakdown of academic impact, for papers by Zhongsheng Tong
Rankless by CCL
2026